Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +130.43% and +7.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Fulgent Genetics ranks at the bottom for Revenue Growth and Gross Profit, with negative percentages. It is also at the bottom for Return on Equity, with a negative percentage. Overall, Fulgent ...

Arc Resources 2Q EPS C$0.68; 2Q Net C$396.1M; 2Q Avg Production 357,228 BOE/Day; 2Q Funds From Operations C$682M, or C$1.17/Share; Boosts 2025 Capital Spending Plan to C$1.85B-C$1.95B; Sees 2025 ...

Detailed price information for Fulgent Genetics Inc (FLGT-Q) from The Globe and Mail including charting and trades.

Get the cash flow statement for Fulgent Genetics, Inc. (FLGT). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue.

September S&P 500 E-Mini futures (ESU25) are down -0.93%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are down -1.03% this ...

EL MONTE, Calif., July 17, 2025--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business ...

View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Fulgent Genetics, Inc. (FLGT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.